BioSpace News Archive

There are many common misbeliefs around chronic procrastinators. they don’t care about work; they are lazy, etc. Here are some steps for overcoming procrastination.

St. Louis, Missouri is one of the fastest-growing and top-ranked emerging life sciences markets in the U.S., ranking sixth in a recent CBRE Research report.

Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, announced that it has acquired marketing approval for Revcovi 2.4 mg for intramuscular injection [Elapegademase] from the Ministry of Health, Labor and Welfare .

The prevalence of using antidepressants and proton pump inhibitors increases after the diagnosis of Alzheimer’s disease, according to a doctoral dissertation from the University of Eastern Finland.

Soligenix, Inc announced its recent accomplishments and financial results for the year ended December 31, 2018.

Theralase Technologies Inc. is pleased to announce that the results of the Phase Ib clinical study will be presented at the 17th International Photodynamic Association World Congress, to be held in Cambridge, Massachusetts from June 28th to July 4th, 2019.

The four winners of the Khalifa Fund for Enterprise Development and startAD’s Ibtikari (My Innovation) program, which aims to inspire Emiratis to come up with innovative ideas across various fields, recently presented their projects during Ibtikari Demo Day held in conjunction with Angel Rising Investor Education Symposium at New York University Abu Dhabi.

Clinical Network Services USA, an integrated services group focused on clinical product development and subsidiary of Asia-Pacific specialist CRO Novotech, announced the appointment of Dr Robert Malone as Principal Consultant in its Washington D.C. office.

GATTO Study Extension to Evaluate Gatipotuzumab and Tomuzotuximab or marketed anti-EGFR Monoclonal Antibody Drugs in refractory metastatic solid tumors

Duke University has agreed to pay the U.S. government more than $112 million to settle allegations that a university-associated researcher falsified claims in order to obtain funding from the National Institutes of Health and other federal agencies.